FR3066492B1 - Derives de resorcinol pour leur utilisation cosmetique - Google Patents

Derives de resorcinol pour leur utilisation cosmetique Download PDF

Info

Publication number
FR3066492B1
FR3066492B1 FR1754295A FR1754295A FR3066492B1 FR 3066492 B1 FR3066492 B1 FR 3066492B1 FR 1754295 A FR1754295 A FR 1754295A FR 1754295 A FR1754295 A FR 1754295A FR 3066492 B1 FR3066492 B1 FR 3066492B1
Authority
FR
France
Prior art keywords
cosmetic use
resorcinol derivatives
compounds
relates
resorcinol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1754295A
Other languages
English (en)
Other versions
FR3066492A1 (fr
Inventor
Xavier Marat
Chunyu MA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR1754295A priority Critical patent/FR3066492B1/fr
Priority to PCT/EP2018/062742 priority patent/WO2018210933A1/fr
Publication of FR3066492A1 publication Critical patent/FR3066492A1/fr
Application granted granted Critical
Publication of FR3066492B1 publication Critical patent/FR3066492B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3882—Arylalkanephosphonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
    • C07F9/657181—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne des composés de formule (I) dérivés de résorcinol ainsi que leurs sels, leurs solvates et leurs isomères optiques et/ou géométriques, y compris énantiomères et diastéréoisomères, leurs racémiques, seuls ou en mélange. L'invention concerne également un procédé cosmétique de dépigmentation, d'éclaircissement et/ou de blanchiment des matières kératiniques, notamment de la peau utilisant ces composés (I).
FR1754295A 2017-05-16 2017-05-16 Derives de resorcinol pour leur utilisation cosmetique Expired - Fee Related FR3066492B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1754295A FR3066492B1 (fr) 2017-05-16 2017-05-16 Derives de resorcinol pour leur utilisation cosmetique
PCT/EP2018/062742 WO2018210933A1 (fr) 2017-05-16 2018-05-16 Utilisation cosmétique de dérivés du résorcinol

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1754295 2017-05-16
FR1754295A FR3066492B1 (fr) 2017-05-16 2017-05-16 Derives de resorcinol pour leur utilisation cosmetique

Publications (2)

Publication Number Publication Date
FR3066492A1 FR3066492A1 (fr) 2018-11-23
FR3066492B1 true FR3066492B1 (fr) 2019-05-03

Family

ID=59746033

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1754295A Expired - Fee Related FR3066492B1 (fr) 2017-05-16 2017-05-16 Derives de resorcinol pour leur utilisation cosmetique

Country Status (2)

Country Link
FR (1) FR3066492B1 (fr)
WO (1) WO2018210933A1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2704428B1 (fr) * 1993-04-29 1995-06-09 Oreal Utilisation de dérivés de la résorcine substitués en position(s) 4, 4 et 5 ou 4 et 6 dans des compositions cosmétiques ou dermopharmaceutiques à action dépigmentante.
FR2734825B1 (fr) 1995-05-31 1997-07-18 Oreal Procede de separation de la melanine presente dans des cellules
JPH11255638A (ja) 1998-03-13 1999-09-21 Kansai Kouso Kk チロシナーゼ活性阻害剤及び化粧料

Also Published As

Publication number Publication date
WO2018210933A1 (fr) 2018-11-22
FR3066492A1 (fr) 2018-11-23

Similar Documents

Publication Publication Date Title
WO2019035863A8 (fr) Activateurs de la pyruvate kinase destinés à être utilisés dans le traitement de troubles hématologiques
MA55533B1 (fr) Agents de modulation de régulateur de conductance transmembranaire de fibrose kystique
MA46357B1 (fr) Modulateur de régulateur de conductance transmembranaire de fibrose kystique, compositions pharmaceutiques, procédés de traitement et procédé de fabrication du modulateur
MA42341B2 (fr) Inhibiteur de protéine kinase, son procédé de préparation et son utilisation médicale
MA39783A (fr) Dérivés de quinoxaline utiles en tant que modulateurs de la fgfr kinase
UY31084A1 (es) Compuestos de azaindol para la inhibicion de b-secretasa
PE20180462A1 (es) Moduladores cot y metodos de uso de los mismos
MA31683B1 (fr) Composes et procedes pour moduler fxr
BR112013009365A2 (pt) uso de um composto da seguinte fórmula (i) ou um sal farmaceuticamente aceitável solvato ou composição do mesmo, composto da formula (i), composição farmaceutica, metodo para o tratamento de uma condição ou desordem em que bloqueadores de canal ttx-s estao envolvidos em um animal, incluindo um humano e processo para preparar uma composiçao farmaceutica.
FR2959666A1 (fr) Composition cosmetique moussante a base d'acide ellagique ou d'un de ses derives et d'huile essentielle.
MX2021009806A (es) Ésteres de ácidos grasos de cadena media de beta-hidroxibutirato y butanodiol y composiciones y métodos para usar los mismos.
UY31083A1 (es) Derivados de sulfoximinas para la inhibicion de b-secretasa
MA39707B1 (fr) Dérivés de 1,2-dihydro-3h-pyrrolo [1,2-c]imidazol-3-one et leur utilisation comme agents antibactériens
MA38948A1 (fr) Dérivés de 2h-indazole antibactériens
TN2011000669A1 (fr) L-serine pour son utilisation en tant que medicament pour prevenir et/ou traiter une reaction inflammatoire de la peau
MX2021004134A (es) Benzoxazol y compuestos relacionados útiles como moduladores de autofagia mediada por chaperonas.
BR112013024368A8 (pt) Combinações de composto ativo
CO2022008690A2 (es) Compuestos heterocíclicos como inhibidores de delta-5 desaturasa y métodos de uso
FR3044899B1 (fr) P-phenylenediamines substituees en tant que nouveaux precurseurs de colorants d'oxydation du type revelateur
BR112022006250A2 (pt) Compostos heterobicíclicos de arila como bloqueadores de canal de agitador de potássio kv1.3
MA38009B1 (fr) Composes d'azaindoline substitues qui ont une activite inhibitrice de la proteine d'apoptose pour leurs utilisations dans le traitement et/ou la prophylaxie du cancer
FR3045039B1 (fr) Derives de resorcinol pour leur utilisation cosmetique
MA39926B1 (fr) Dérivés de dihétérocycle liés à cycloalkyle
FR3045600B1 (fr) Derives de resorcinol pour leur utilisation cosmetique
MX2024008333A (es) Compuestos para tratamiento de pérdida de cabello.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20181123

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

ST Notification of lapse

Effective date: 20240105